Wellgistics Health Reports Strong Q1 Operational Growth Across Manufacturer, Product, and Pharmacy Expansion with Over 350 New Pharmacies Added to Its Nationwide Network

Rhea-AI Summary

Wellgistics Health (NASDAQ:WGRX) reported robust operational growth in Q1 2025, marking significant expansion across multiple business segments. The company achieved three major milestones:

• Added 354 new independent pharmacies to its nationwide network
• Onboarded 22 new pharmaceutical manufacturers
• Integrated 57 new prescription drug products into its portfolio

CEO Brian Norton emphasized that these results demonstrate strong industry demand for change. The company is focused on streamlining pharmaceutical distribution by creating a direct, transparent pathway between manufacturers, pharmacies, and patients. Wellgistics Health's strategy aims to empower independent pharmacies, helping them transition from survival to leadership roles by providing improved pricing, tools, and supply chain access. This growth represents a shift away from traditional "Big Three" dominance toward more efficient, pharmacy-first solutions.

Positive

• Added 354 new independent pharmacies to network in Q1 2025, showing strong market penetration
• Onboarded 22 new pharmaceutical manufacturers, expanding supplier base
• Integrated 57 new prescription drug products into portfolio, diversifying product offerings

Negative

• Financial metrics and revenue impact of expansion not disclosed
• Unaudited operational results presented without concrete financial data

News Market Reaction

-0.92%

1 alert

-0.92% News Effect

On the day this news was published, WGRX declined 0.92%, reflecting a mild negative market reaction.

Data tracked by StockTitan Argus on the day of publication.

TAMPA, FL / ACCESS Newswire / April 30, 2025 / Wellgistics Health, Inc. (NASDAQ:WGRX) ("Wellgistics Health"), a holding company for various existing and planned strategic businesses centered around healthcare technology and pharmaceutical services, today announced key unaudited operational performance highlights for the first quarter of 2025, signaling continued acceleration across its national platform.

Some of Wellgistics Health's Q1 2025 operational highlights include:

• 354 new independent pharmacies added

• 22 new pharmaceutical manufacturers onboarded

• 57 new prescription drug products integrated into the portfolio

"These numbers are a clear signal the industry is demanding change," said Brian Norton, CEO of Wellgistics Health. "We're cutting through the noise of bloated, outdated systems and building an innovative, direct, transparent path between manufacturers, pharmacies, and patients-with real accretive results becoming apparent."

Wellgistics Health is equipping independent pharmacies with the pricing, tools, and supply chain access needed to migrate from a survival to a leadership role. As the industry shifts, this growth reflects a clear departure from the Big Three status quo towards faster, more equitable, and more pharmacy-first solutions.

About Wellgistics Health, Inc.

Wellgistics Health, Inc. (NASDAQ:WGRX) is a holding company for existing and future planned operating companies centered around healthcare technology and pharmaceutical services. It seeks to be a micro health ecosystem, with a portfolio of companies consisting of a technology platform, pharmacy, and wholesale operations that provide novel prescription hub and clinical services. Wellgistics Health is focused on improving the lives of patients while delivering unique solutions for pharmacies, providers, pharmaceutical manufacturers, and payors. With the successful integration of its patient-centric approach and innovative healthcare applications, Wellgistics Health intends to shift the dynamic of pharmaceutical care to revolve around the patient for a wide range of therapeutic conditions by offering a full spectrum of integrated solutions as a result of leveraging the synergies of its business segments to address access, care coordination, dispensing, delivery, and clinical management of pharmaceutical products ranging from "specialty-lite" to general maintenance conditions. For more information, please visit the Wellgistics Health's website: https://wellgisticshealth.com/.

Forward-Looking Statements

This press release may contain forward-looking statements. Forward-looking statements include statements concerning plans, objectives, goals, strategies, future events or performance, and underlying assumptions and other statements that are other than statements of historical facts. When Wellgistics Health uses words such as "may, "will, "intend," "should," "believe," "expect," "anticipate," "project," "estimate" or similar expressions that do not relate solely to historical matters, it is making forward-looking statements. These forward-looking statements include, without limitation, Wellgistics Health's statements regarding Wellgistics Health's strategy and descriptions of its future operations, prospects, and plans. Forward-looking statements are not guarantees of future performance and involve risks and uncertainties that may cause the actual results to differ materially from Wellgistics Health's expectations discussed in the forward-looking statements. These statements are subject to uncertainties and risks including, but not limited to, the uncertainties related to market conditions and other risks detailed in our reports and statements filed with the SEC. For these reasons, among others, investors are cautioned not to place undue reliance upon any forward-looking statements in this press release. Additional factors are discussed in Wellgistics Health's filings with the SEC, which are available for review at www.sec.gov.

For more information, please contact:

IR@wellgistics.com

SOURCE: Wellgistics Health, Inc.

View the original press release on ACCESS Newswire

FAQ

How many new pharmacies did Wellgistics Health (WGRX) add in Q1 2025?

Wellgistics Health added 354 new independent pharmacies to its nationwide network during Q1 2025, showing significant expansion of its healthcare platform.

What are the key operational growth metrics for WGRX stock in Q1 2025?

In Q1 2025, Wellgistics Health reported three key growth metrics: 354 new independent pharmacies added, 22 new pharmaceutical manufacturers onboarded, and 57 new prescription drug products integrated into their portfolio.

How is Wellgistics Health (WGRX) competing against the Big Three pharmaceutical distributors?

Wellgistics Health is challenging the Big Three status quo by providing independent pharmacies with better pricing, tools, and supply chain access, helping them transition from survival to leadership roles in the industry.

How many new pharmaceutical manufacturers joined Wellgistics Health's network in Q1 2025?

Wellgistics Health onboarded 22 new pharmaceutical manufacturers during the first quarter of 2025, expanding their manufacturer network.

What is Wellgistics Health's (WGRX) strategy for independent pharmacies?

Wellgistics Health's strategy focuses on providing independent pharmacies with competitive pricing, improved tools, and enhanced supply chain access to help them become industry leaders rather than just survivors.